Marker Therapeutics, Inc.
US UEI CK3KR85CSP23 · SME
7public awards
$14.1Mtotal public funding
2026-07-24latest award
State aid awards (7)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-07-24 | $4.2M | Grant | MILITARY MEDICAL RESEARCH AND DEVELOPMENT | Department of Defense |
| 2026-07-20 | $2.0M | Grant | CANCER TREATMENT RESEARCH | Department of Health and Human Services |
| 2026-04-17 | $1.2M | Grant | FOOD AND DRUG ADMINISTRATION RESEARCH | Department of Health and Human Services |
| 2024-09-01 | $1.3M | Grant | A Phase 1 Study of Patient-Derived Multi-Tumor Associated Antigen Spec | Department of Health and Human Services |
| 2024-08-01 | $1.3M | Grant | A Phase 1 Study of Patient-Derived Multi-Tumor-Associated Antigen Spec | Department of Health and Human Services |
| 2024-06-14 | $2.0M | Grant | Controlling Tumor Immune Escape in Pancreatic Cancer using a Dual T Ce | Department of Health and Human Services |
| 2023-08-10 | $2.0M | Grant | Phase 2 clinical trial of a novel T cell therapy following bridging th | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →